|
2011
|
Invention
|
Marker for cells. The present invention is related to a lipid content of a cell and its use in de... |
|
|
Invention
|
Method for isolating cells and a cell population thereof. The present invention is directed to a ... |
|
|
Invention
|
Use of blood group status iii. The present invention relates to a microbial composition which is ... |
|
|
Invention
|
Use of blood group status. The present invention relates to use of the non- secretor/secretor blo... |
|
|
Invention
|
Device for simulation. An in-vitro solution for simulating the growth of microbes in the presence... |
|
|
Invention
|
Induced proteins. The present invention relates to a method for inducing changes in the proteome ... |
|
|
Invention
|
Use of abo type. The present invention relates to use of the ABO blood group genotype of an indiv... |
|
|
Invention
|
Method for isolating cd34+ hematopoietic stem cells, natural killer cells and regulatory t lympho... |
|
|
Invention
|
Sulphated hyaluronic acid in combination with g-csf for use in mobilising blood stem cells. The p... |
|
|
Invention
|
Use of a proteolytic enzyme for the modification of the cell surface of a stem cell. The present ... |
|
|
Invention
|
Method of detecting the differentiation status of a stem cell population. The present invention r... |
|
2010
|
Invention
|
Probiotic bifidobacterial composition in accordance with secretor blood group status. The present... |
|
|
Invention
|
Method of distinguishing undifferentiated mesenchymal stem cells and differentiated mesenchymal s... |
|
|
Invention
|
Use of blood group status iii.
Provided is a microbial composition which is tailored based on th... |
|
|
Invention
|
Use of blood group status i.
Provided is a probiotic composition which is tailored based on the ... |
|
|
Invention
|
Use of blood group status ii.
Provided is a microbial or probiotic composition which is tailored... |
|
|
Invention
|
Use of animal cells for screening probiotic bacteria strains.
The present invention relates to a... |
|
|
Invention
|
Use of animal cells for screening probiotic bacteria strains. The present invention relates to an... |
|
|
Invention
|
Cell surface profile. The present invention relates to a method of characterizing and/or identify... |
|
|
Invention
|
Antibodies directed to tra antigens, and methods of production, screening and analysis of said an... |
|
|
Invention
|
An antibody-glycan complex targeting the disialyl core ii and sialyl lewis x structures, and uses... |
|
2009
|
Invention
|
Method of protecting cells.
Provided is a method for protecting stem cells in a clinical graft a... |
|
|
Invention
|
Method of protecting cells. The present invention relates to a method of protecting stem cells in... |
|
|
Invention
|
Enzymatical modif ication of cell glycosylation using serum albumin and divalent cations. The inv... |
|
|
Invention
|
A method of evaluating the integrity of the plasma membrane of cells by detecting glycans found o... |
|
|
Invention
|
Culture of cells. The invention relates to a method for culturing human embryonic stem cells (hES... |
|
2008
|
Invention
|
Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid e... |
|
|
Invention
|
Culture of human embryonic cells.
The invention relates to a method for culturing human embryoni... |
|
|
Invention
|
Novel acidic glycan markers of human cells. The invention is directed to the analysis of novel ac... |
|
|
Invention
|
Novel specific cell binders. The invention describes reagents and methods for speficic binders to... |
|
|
Invention
|
Method for modifying cells. The invention describes specific sialylated structures present on hum... |
|
|
Invention
|
Novel methods and reagents directed to production of cells. The present invention provides method... |
|
|
Invention
|
Novel carbohydrate from human cells and methods for analysis and modification thereof. The invent... |
|
|
Invention
|
Novel carbohydrate profile compositions from human cells and methods for analysis and modificatio... |
|
2007
|
Invention
|
Novel cellular glycan compositions. The invention describes novel compositions of glycans, glycom... |
|
2006
|
Invention
|
Method for evaluating cell populations. The invention describes specific sialylated structures pr... |
|
|
Invention
|
Method of profiling a cell population. The present invention relates to a method of profiling a c... |
|
2005
|
Invention
|
Process for the manufacture of virus safe immunoglobulin.
Process for preparing a purified immun... |
|
|
Invention
|
Process for the manufacture of virus safe immunoglobulin. Process for preparing a purified immuno... |
|
|
Invention
|
Pharmaceutical compositions. Liquid composition of antibodies, such as immunoglobulin G, immunogl... |
|
2001
|
Invention
|
Methods and active substances for protecting organs. The present invention comprises a method of ... |
|
1999
|
Invention
|
Pharmaceutical composition comprising human apotransferrin and process for manufacturing of the c... |
|
|
Invention
|
Method for preparing virus-safe pharmaceutical compositions. The present invention concerns a met... |
|
|
Invention
|
Alpha-interferon manufacturing process using immunoadsorption and virus removal filtration. The p... |
|
1998
|
Invention
|
Preparation of immunoglobulin. The invention relates to a method for producing an immunoglobulin ... |
